UK Public Sector Contracts & Tenders

The Specification sets out the requirements for the Personal Dosimetry Service to be delivered under contract to the Authority. The service encompasses the supply, distribution, collection, processing, and reporting of personal dosimeters worn by classified radiation workers across the Authority’s site.<br/>The Authority is required under the Ionising Radiations Regulations 2017 (IRR17) requires GHNHSFT as a radiation employer to risk assess all work with ionising radiation and potential radiation exposure to staff during their work and identify whether staff require personal dose monitoring or SHOULD be designated as classified persons. Personal dose monitoring is used to demonstrate that doses are as low as Reasonably practicable (ALARP) & compliant with regards to the Dose limits (Schedule 3 of the Ionising Radiations Regulations 2017. It is an offense under IRR17 to exceed the dose limits. The Supplier must demonstrate full compliance with these obligations and with all relevant legislation, standards and guidance as specified herein.<br/>Employers are responsible for dose assessment & recording (reg 22). Prompt investigation of overexposure where a dose to a worker exceeds dose limits is required (Reg 26), review of staff dose monitoring records enables investigations to be carried out when lower local dose investigation levels are exceeded to ensure learning and other actions are taken before the individual exceeds the statutory dose limits.<br/>For all workers designated as Classified Persons (Reg 36) the radiation employer (GHNHSFT) MUST employ an Approved Dosimetry Service (Reg 22) which has HSE approval for dose assessment, co-ordination, record keeping and sharing of dose information with the HSE’s central index of Dose information (CIDI).<br/>The current contract for the provision of HSE Approved Dosimetry Services is held with the Radiation physics and Protection Services (RRPPS) ADS at University Hospitals Birmingham. Tender reference RFT43347 which was commenced on 01/08/2021, for an initial period of 3 years with and extension clause of up to 2 years and therefore the contract is due for renewal & retender in August 2026.<br/>The purpose of this scope is to define the requirements for the provision of a comprehensive, compliant, and reliable personal dosimetry and environmental radiation dose monitoring service to support radiation protection, regulatory compliance, and occupational safety for staff, patients, the public, and the environment.

Master Vendor Contract for non-clinical staff for Gloucestershire. This indicative spend includes the supplier fees and staff day rates.

Master Vendor Contract for provision of Nursing and Medical Locums for Gloucestershire. This indicative spend includes the supplier fees and staff day rates.

Gloucestershire Hospitals NHS Foundation Trust (GHFT) provides acute hospital services from two large district general hospitals, Cheltenham General Hospital (CGH) and Gloucestershire Royal Hospital (GRH). Maternity Services are also provided at Stroud Maternity Hospital. GHFT Pathology services are critical in supporting the delivery of a high-quality, first-class clinical service that can meet the demand and needs of the acute Trust and our One Gloucestershire partners (Gloucestershire Primary care, Gloucestershire Health and Care NHS Foundation Trust), South Worcestershire Primary care, private healthcare providers and other out of county NHS healthcare organisations. The Pathology disciplines are spread across two sites (GRH and CGH), with Haematology, Blood transfusion, and Chemical Pathology provided at both sites due to the acute clinical services at each site. Cellular Pathology services are consolidated and are based at CGH, and Immunology and Microbiology services are consolidated and are based at GRH. Several managed service contracts are due to expire, the most significant ones in October 2026. As a minimum, replacement of the current contracts must ensure ongoing service provision, as Pathology services are a fundamental diagnostic and prognostic service that supports every aspect of patient care, where 70% to 80% of clinical decisions and 95% of chronic disease pathways are reliant upon input from Pathology. However, national and local demand for Pathology services has increased and become more complex over the last 10 years, and the ability to deliver Pathology services fit for the future, is currently constrained by the estate occupied by GHFT Pathology disciplines. Each discipline has unique estate (e.g. space, storage capacity, temperature control, layout) and workflow challenges, that need to be reconfigured to deliver the operational efficiency and lean process required in a modern-day NHS laboratory, and to provide income generating capacity through analytical suites that offer bespoke analysis to other NHS organisations, organisations carrying out research and innovation, other areas of the private sector (e.g. sports medicine, veterinarians and private patients). GHFT Pathology disciplines: • Cellular Pathology (includes Histopathology and Cytology) • Chemical Pathology • Haematology, Immunology and Blood Transfusion • Infection Sciences (includes Microbiology, Serology and Molecular Microbiology) • Point of Care Testing Our proposed scope is looking to include Pathology Managed Services relating to all Pathology disciplines with the remit to cover but not limited to: • Capital, Instruments & Devices • Reagents, Chemicals & Consumables • Maintenance • IT, AI & Software Integration • Estate upgrades